Clinical Trials Sponsored by National Neuroscience Institute

Total 44470 results

National Eye Institute (NEI)

Completed

Blood and Saliva Sample Collection for AREDS 2

Eye Diseases | Age-Related Macular Degeneration

United States
National Cancer Institute (NCI)

Completed

Pomalidomide for Chronic Graft-versus-Host Disease

Graft vs Host Disease | Graft-Versus-Host Disease

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors

Brain Cancer | Brain Neoplasm | Brain Tumor, Primary

United States
National Cancer Institute (NCI)

Completed

18F-DCFBC PET/CT in Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Adenocarcinoma | Breast Cancer | Colorectal Cancer | Ovarian Cancer

United States
National Cancer Institute (NCI)

Terminated

Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor

Kidney Cancer | Renal Cancer

United States
National Cancer Institute (NCI)

Withdrawn

Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)

Neoplasms, Nerve Tissue | Peripheral Nervous System Diseases | Heredodegenerative Disorders, Nervous System | Neurofibromatosis 1
National Eye Institute (NEI)

Completed

Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration

AMD

United States
National Cancer Institute (NCI)

Completed

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Neoplasms | Lymphomas

United States
National Eye Institute (NEI)

Completed

Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On

Cancer | Cataract | AMD

United States
National Cancer Institute (NCI)

Completed

Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System

Multiple Myeloma | Hodgkin's Lymphoma | Acute Leukemia | Myelodysplastic Syndrome | Non-Hodgkin's Disease

United States
National Cancer Institute (NCI)

Completed

AMG 386 and Abiraterone for Advanced Prostate Cancer

Prostatic Neoplasms | Prostate Cancer | Neoplasm, Prostate | Neoplasm,Prostatic

United States
National Cancer Institute (NCI)

Completed

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

T-Cell Large Granular Lymphocytic Leukemia | Leukemia, T-Cell Large Granular Lymphocytic

United States
National Cancer Institute (NCI)

Terminated

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Thyroid Neoplasms | Differentiated Thyroid Cancer | Poorly Differentiated and Undifferentiated Thyroid Cancer

United States
National Eye Institute (NEI)

Completed

Genetics and Markers of Degenerative and Inflammatory Eye Diseases

Uveitis | Diabetic Retinopathy | Age-Related Macular Degeneration (AMD)

United States
National Cancer Institute (NCI)

Terminated

A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer

NSCLC | Stage IIIA (N2)

United States, Croatia
National Cancer Institute (NCI)

Completed

Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease

Von Hippel-Lindau Disease

United States
National Cancer Institute (NCI)

Completed

Phase II Study of Vandetanib in Individuals With Kidney Cancer

Renal Cancer | Von Hippel Lindau

United States
National Cancer Institute (NCI)

Completed

AZD2171 to Treat Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Withdrawn

Gut Microbiota in People With Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Liver Neoplasm | Liver Cancer | Liver Cell Caricinoma
National Cancer Institute (NCI)

Withdrawn

Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

Primary Effusion Lymphoma | Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease
National Cancer Institute (NCI)

Completed

TKM 080301 for Primary or Secondary Liver Cancer

Colorectal Cancer With Hepatic Metastases | Pancreas Cancer With Hepatic Metastase | Gastric Cancer With Hepatic Metastase | Breast Cancer With Hepatic Metastase | Ovarian Cancer With Hepatic Metastase

United States
National Cancer Institute (NCI)

Completed

Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma

Sarcoma, Kaposi

United States
National Eye Institute (NEI)

Completed

Rituximab for Autoimmune Retinopathy

Autoimmune Disease

United States
National Cancer Institute (NCI)

Withdrawn

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

Carcinoma, Non-Small-Cell Lung | Thymus Neoplasms
National Cancer Institute (NCI)

Completed

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

Multiple Myeloma | Chronic Lymphocytic Leukemia | Graft vs Host Disease | Non Hodgkin's Lymphoma | Hodgkin's Disease

United States
National Cancer Institute (NCI)

Completed

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

Sarcoma | Neuroectodermal Tumors, Primitive, Peripheral | Neuroblastoma | Rhabdomyosarcoma-Embryonal | Rhabdomyosarcoma- Alveolar

United States
National Cancer Institute (NCI)

Completed

A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment

Cancer | Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

Peritoneal Mesothelioma | Pleural Mesothelioma

United States
National Eye Institute (NEI)

Completed

Clinical and Genetic Studies of Families With Congenital or Hereditary Cataracts

Cataract

United States, China, India, Italy, Pakistan
National Eye Institute (NEI)

Completed

AMD Phenotype and Genotype Study

Age-Related Macular Degeneration | AMD

United States, Germany
National Cancer Institute (NCI)

Completed

Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191

Cervical Neoplasia | HPV Infections

Costa Rica
National Cancer Institute (NCI)

Completed

Testing the FLASHE Survey

Survey | Interview | Cognitive Testing

United States
National Cancer Institute (NCI)

Completed

HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda

HPV16 Anitbody Levels Post Vaccination | HPV18 Antibody Levels Post Vaccination

Uganda
National Cancer Institute (NCI)

Completed

Feasibility Study for Prospective Diet and Lifestyle Cohorts in Delhi, Kerala, and Kolkota, India

Chronic Diseases

India
National Cancer Institute (NCI)

Completed

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Cervical Cancer | Anal Cancer | Vaginal Cancer | Oropharyngeal Cancer | Penile Cancer

United States
National Eye Institute (NEI)

Completed

Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure

Menopause | Turner Syndrome | Ovarian Failure, Premature | Sex Chromosome Aberrations | Perimenopause

United States
National Cancer Institute (NCI)

Completed

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas

Lymphoma | Cutaneous | T-Cell

United States
National Eye Institute (NEI)

Completed

Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease Study

AMD | Age- Related Macular Degeneration

United States
National Cancer Institute (NCI)

Completed

TRC105 for Liver Cancer That Has Not Responded to Sorafenib

Carcinoma, Hepatocellular | Hepatocellular Carcinoma | Hepatocellular Cancer

United States
National Cancer Institute (NCI)

Withdrawn

In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma

Metastatic Melanoma
National Cancer Institute (NCI)

Completed

Genetic and Protein Profiling in Normal and Cancerous Breast Tissue

Breast Neoplasms

United States
National Eye Institute (NEI)

Completed

Screening for Studies on Retinovascular Diseases

Macular Degeneration | Diabetic Retinopathy | Retinal Disease | Pathologic Neovascularization

United States
National Eye Institute (NEI)

Completed

Investigating Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
National Cancer Institute (NCI)

Completed

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

Lymphoma | Follicular Lymphoma | B Cell Lymphoma

United States
National Eye Institute (NEI)

Completed

Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth

Neovascularization

United States
National Cancer Institute (NCI)

Completed

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Breast Cancer

United States
National Eye Institute (NEI)

Completed

Combination Daclizumab/Denileukin Diftitox to Treat Uveitis

Non-infectious Intermediate and Posterior Uveitis

United States

Clinical Trials Sponsored by National Neuroscience Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations